Skip to main content
. 2016 Nov 10;99(6):1338–1352. doi: 10.1016/j.ajhg.2016.09.022

Table 2.

Summary of Autosomal-Recessive ASD CPAMD8 Mutations

Family Exon or Intron Nucleotide Change Protein Change PolyPhen-2 (Human Variation Score 0–1) SIFT (Tolerance Index 0–1) PhyloP UCL-ex (Exomes) 1000 Genomes NHLBI EVS Total Alleles ExAC Total Alleles
Het. Homo.
1 exon 32 c.4351T>C p.Ser1451Pro PRD (0.948) damaging (0.01) conserved (0.98) 0/1,980 0 0/12,378 0/116,178 0/116,178
2 exon 18 c.2352_2353insC p.Arg785Glnfs23 NA NA NA 0/1,980 0 21/11,520 47/115,670 0/115,670
intron 33 c.4549–1G>A p.? NA NA NA 0/1,980 0 1/12,356 1/120,688 0/120,688
3 intron 7 c.700+1G>T p.? NA NA NA 0/1,980 0 0/12,140 0/120,212 0/120,212
intron 29 c.4002+1G>A p.? NA NA NA 0/1,980 0 0/12,350 0/120,350 0/120,350

In silico analysis of rare CPAMD8 variants identified. PolyPhen-2 appraises mutations quantitatively as benign, possibly damaging, or probably damaging (PRD) on the basis of the model’s false-positive ratio. SIFT results are reported to be tolerant if tolerance index is ≥0.05 or intolerant if tolerance index is <0.05. PhyloP prediction is conserved if score is >0.95, otherwise non-conserved. The cDNA is numbered according to GenBank: NM_015692.2. Abbreviations are as follows: NA, not available; UCL-ex, University College London (UCL) exomes consortium; NHLBI EVS, National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project Exome Variant Server (EVS); ExAC, Exome Aggregation Consortium; Het., heterozygote; Homo., homozygote.